ENDometriosis: Evaluation of Detection and Need for ALGOlogic Care Before Surgery

NCT ID: NCT06997809

Last Updated: 2025-05-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

187 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-31

Study Completion Date

2028-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Endometriosis surgery is required when medical treatment fails to release women from pain. However, complete surgery does not work every time to improve patients' symptoms. Algological care is one of the options to treat the pain before surgery and their related complications (neuropathy, sensitization, and catastrophism) that could be associated to nociceptive pain.

But not all patients could benefit from this pathway and no screening strategy does exist to detect these complications that could be treated prior to endometriosis surgery

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Endometriosis, Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

Surgery without calculation of pain questionnaire scores

Group Type NO_INTERVENTION

No interventions assigned to this group

group with adapted support

The calculation of pain questionnaire scores is carried out to direct or not the patient towards pain consultations before surgery.

Only patients with at least one positive test benefit from an algology consultation before surgery.

Group Type EXPERIMENTAL

pathway care

Intervention Type OTHER

Group for whom the test results will be used to determine the management strategy. If one of the tests performed before randomization is positive an algological consultation before surgery will be performed with an adapted treatment. Then surgical treatment as planned.

If all tests are negative, surgical treatment is performed. The dedicated algology consultation must be done with an experienced practitioner different from the one who will perform the surgery. A rapid algological treatment circuit must be put in place to maintain the surgery date set.

Group without using the results of test for associated pain components. Standard surgical treatment as planned through dedicated staff on endometriosis treatment.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

pathway care

Group for whom the test results will be used to determine the management strategy. If one of the tests performed before randomization is positive an algological consultation before surgery will be performed with an adapted treatment. Then surgical treatment as planned.

If all tests are negative, surgical treatment is performed. The dedicated algology consultation must be done with an experienced practitioner different from the one who will perform the surgery. A rapid algological treatment circuit must be put in place to maintain the surgery date set.

Group without using the results of test for associated pain components. Standard surgical treatment as planned through dedicated staff on endometriosis treatment.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Maternal age from 18 up to 50 years old (50 non included).
* Women affiliated to social coverage insurance
* Women who understand French
* Women who signed the written consent
* Women with impaired quality of life (pain) linked to endometriosis
* Women with formal radiological signs of endometriosis (MRI lesions more than 5 mm or endometrioma more than 20 mm on radiological examinations).
* Surgical indication for resection of lesions by laparoscopy or robotic surgery for management of pain or impairment of quality of life
* Patients requiring complete conservative or radical resections of all lesions
* Indication of surgery validated within dedicated meeting for endometriosis.
* Purpose of pain associated or not with infertility
* Date of surgery fixed with sufficient time for algological treatment. Maximum delay of 4 months between randomization and surgery

Exclusion Criteria

* Women undergoing surgery for the purpose of infertility
* Patient with previous surgery for removal of deep lesions of endometriosis or endometriotic cysts (history of exploratory laparoscopy accepted)
* Patient with suspicious lesions on MRI or specialized ultrasound.
* A patient who needs to be treated for another uterine pathology at the same time.
* Pregnant women
* Patient with a desire for pregnancy immediately and/or within one year after surgery
* Women who refuse clinical examination (some algological tests couldn't be performed without clinical examination)
* Patient who has already received algological treatment or who should receive it before surgery
* Patient with previous other psychiatric disorders (depressive symptoms treated)
* Women without rights
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Limoges

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

François Dr. Margueritte

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Limoges

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bordeaux University Hospital

Bordeaux, France, France

Site Status

IFEMENDO

Bordeaux, France, France

Site Status

Versailles Hospital

Le Chesnay, France, France

Site Status

Saint-Vincent-de-Paul Hospital

Lille, France, France

Site Status

Limoges University hospital

Limoges, France, France

Site Status

Poissy-St-Germain Intercommunal hospital center

Poissy, France, France

Site Status

Poitiers University Hospital

Poitiers, France, France

Site Status

Mutual Clinic La Sagesse

Rennes, France, France

Site Status

South Hospital Rennes University Hospital

Rennes, France, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Safirah AKOWANOU

Role: CONTACT

+33555058755

Abdeslam BEN TALEB

Role: CONTACT

+33555058616

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Valérie BERNARD

Role: primary

05 57 62 34 72

Horace ROMAN

Role: primary

06 50 13 92 54

Pierre PANEL

Role: primary

01 39 63 97 33

Jean-Philippe LUCOT

Role: primary

03 20 00 45 52

Francois MARGUERITTE

Role: primary

0555056164

Arnaud FAUCONNIER

Role: primary

01 39 27 52 51

Xavier FRITEL

Role: primary

05 49 44 39 45

Claire-Marie ROGER

Role: primary

02 99 85 77 92

Krystel NYANGOH TIMOH

Role: primary

06 72 13 60 50

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

87RI23_0049 (ENDALGO)

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Surgery and ART For Endometrioma
NCT03717870 NOT_YET_RECRUITING NA
Compliance and Endometriosis
NCT05619757 COMPLETED
Endometriosis Pain
NCT06101303 RECRUITING